Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: Systemic and local regulatory factors

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1392-1402

  Jiang, Qiujie ^a   Li, Qiaoli ^a   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANKYLOSIS PROTEIN; CALCIUM; CALCIUM PHOSPHATE; FETUIN; FETUIN A; MATRIX PROTEIN; PHOSPHATE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CALCIUM CELL LEVEL; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MINERALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; PSEUDOXANTHOMA ELASTICUM; SKIN CULTURE; TISSUE SECTION; VIBRISSA;

ALKALINE PHOSPHATASE; ANIMALS; AORTA; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CALCINOSIS; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; LIVER; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; PROTEINS; PSEUDOXANTHOMA ELASTICUM; VIBRISSAE;

EID: 33847053974     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700729     Document Type: Article

References (43)

1. Beck K, Hayashi K, Nishiguchi B, Le Saux O, Hayashi M, Boyd CD (2003) The distribution of Abcc6 in normal mouse suggests multiple functions for this ABC transporter. J Histochem Cytochem 51:887-902
2. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD (2002) Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 62:6172-7
3. Belinsky MG, Kruh GD (1999) MOAT-E (ARA) is a full length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer 80:1342-9
4. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H et al. (2000) Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25:228-31
5. Boraldi F, Quaglino D, Croce MA, Garcia Fernandez MI, Tiozzo R, Gheduzzi D et al. (2003) Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from pseudoxanthoma elasticum patients. Matrix Biol 22:491-500
6. Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A (2005) Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 42:881-92
7. El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD (2003) Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 44:272-8
8. Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT et al. (2005) Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14:1763-73
9. 2-HS glycoprotein/fetuin-A. J Biol Chem 278:13333-41
10. Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Gotting C (2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52:227-34
11. Hruska KA, Mathew S, Saab G (2005) Bone morphogenetic proteins in vascular calcification. Circ Res 97:105-14
12. Iliás A, Urban Z, Seidl TL, Le Saux O, Sinko E, Boyd CD et al. (2002) Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277:16860-7
13. Jahnen-Dechent W, Schinke T, Trindl A, Müller-Esterl W, Sablitzky F, Kaiser S et al. (1997) Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496-503
14. Jiang Q, Uitto J (2006) Pseudoxanthoma elasticum: a metabolic disease? J Invest Dermatol 126:1440-1
15. Jiang Q-J, Matsuzaki Y, Li K, Uitto J (2005) Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Invest Dermatol 126:325-35
16. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K et al. (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:e10-7
17. Klement JF, Matsuzaki Y, Jiang Q-J, Terlizzi J, Choi HY, Fujimoto N et al. (2005) Targeted ablation of the ABCC6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25:8299-310
18. Kool M, van der Linden M, de Haas M, Baas F, Boorst P (1999) Expression of human MRP6, a homologue of the multidrug resistance protein MRP1, in tissues and cancer cells. Cancer Res 59:175-82
19. Le Saux O, Bunda S, VanWart CM, Douet V, Got L, Martin L et al. (2006) Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol 126:1497-505
20. Le Saux O, Urban Z, Tschuch C, Csiszar K, Bacchelli B, Quaglino D et al. (2000) Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 25:223-7
21. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR et al. (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81
22. Matsuzaki Y, Nakano A, Jiang Q-J, Pulkkinen L, Uitto J (2005) Tissue-specific expression of the ABCC6 gene. J Invest Dermatol 125:900-5
23. Miksch S, Lumsden A, Guenther UP, Foernzler D, Christen-Zach S, Daugherty C et al. (2005) Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6. Hum Mutat 26:235-48
24. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB et al. (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-47
25. Neldner KH (1988) Pseudoxanthoma elasticum. Clin Dermatol 6:1-159
26. Pasquali-Ronchetti I, Garcia-Fernandez MI, Boraldi F, Quaglino D, Gheduzzi D, De Vincenzi Paolinelli C et al. (2006) Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J Pathol 208:54-61
27. Quaglino D, Boraldi F, Barbieri D, Croce A, Tiozzo R, Pasquali Ronchetti I (2005a) Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum. Biochim Biophys Acta 1501:51-62
28. Quaglino D, Sartor L, Garbisa S, Boraldi F, Croce A, Passi A et al. (2005b) Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim Biophys Acta 1741:42-7
29. Renie WA, Pyeritz RE, Combs J, Fine SL (1984) Pseudoxanthoma elasticum: high calcium intake in early life correlates with severity. Am J Med Genet 19:235-44
30. Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J (2000) Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 97:6001-6
31. Ringpfeil F, McGuigan K, Fuchsel L, Kozic H, Larralde M, Lebwohl M et al. (2006) Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosity. J Invest Dermatol 126:782-6
32. Ringpfeil F, Pulkkinen L, Uitto J (2001) Molecular genetics of pseudoxanthoma elasticum. Exp Dermatol 10:221-8
33. Ryan LM (2001) The ank gene story. Arthritis Res 3:77-9
34. 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-66
35. Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, Scheper RJ (2002) MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82:515-8
36. Schurgers LJ, Dissel PE, Spronk HM, Soute BA, Dhore CR, Cleutjens JP et al. (2001) Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol 90:57-63
37. Sherer DW, Singer G, Uribarri J, Phelps RG, Sapadin AN, Freund KB et al. (2005) Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol 53:610-5
38. Spronk HMH, Soute BAM, Schurgers LJ, Cleutjens JPM, Thijssen HHW, DeMey JGR et al. (2001) Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun 289:485-90
39. Struk B, Cai L, Zach S, Ji W, Chung J, Lumsden A et al. (2000) Mutations of the gene encoding the transmembrane transporter protein ABCC6 cause pseudoxanthoma elasticum. J Mol Med 78:282-6
40. Trion A, van der Laarse A (2004) Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart 147:808-14
41. Uitto J, Boyd CD, Lebwohl MG, Moshell AN, Rosenbloom J, Terry S (1998) International Centennial Meeting on Pseudoxanthoma Elasticum: progress in PXE research. J Invest Dermatol 110:840-2
42. Uitto J, Pulkkinen L, Ringpfeil F (2001) Molecular genetics of pseudoxanthoma elasticum - a metabolic disorder at the environment-genome interface? Trends Mol Med 7:13-7
43. Wang W, Xu J, Du B, Kirsch T (2005) Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol 25:312-23